Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 20, 2017
Pharmacy Choice - October 2017 Newsletter - October 20, 2017

Pharmacy Choice Newsletter - October 2017

thePharmacySPOTLIGHT
New Drug Approved for ALS
by Darrell Hulisz, RPh, PharmD
& Foud Bahamdain, Pharmacy Intern
Amyotrophic lateral sclerosis (ALS) is a rare, progressive disorder that involves the degeneration of motor neurons in the brain and spinal cord. Oxidative stress is believed to be the cause of this disorder. Early symptoms included…
READ MORE
 
 
October Disease Focus
Low Back Pain - Updated Treatment Guidelines
by Gina D. Moore, PharmD, MBA
Low back pain is a typical complaint for which patients come to a pharmacy seeking over-the-counter treatment. The prevalence of low back pain in the U.S. is substantial; approximately one out of four adults report experiencing low back pain at least one day during the prior 90 day period. Costs associated with low back pain are also significant in terms of both healthcare dollars and…
 
Pharmacy Announcements
The Rite Aid Foundation announced today a $150,000 donation to the American Red Cross to help the victims, families and communities in Puerto Rico affected by Hurricane Maria.
CAMP HILL, Pa. (Oct. 4, 2017) – The Rite Aid Foundation announced today a $150,000 donation to the American Red Cross to help the victims, families and communities in Puerto Rico affected by Hurricane Maria.

"Nearly two weeks after being hit directly by Hurricane Maria, a category four storm, the need in Puerto Rico remains great," said Tracy Henderson, director of The Rite Aid…
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Desonide Ointment, 0.05%, the generic version of Desonide Ointment, 0.05%, of Perrigo New York Inc.
Mumbai, India; September 19, 2017: Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Desonide Ointment, 0.05%, the generic version of Desonide Ointment, 0.05%, of Perrigo New York Inc.

According to IMS Health sales data for the 12 month period ending July 2017, the Desonide Ointment…
 
Hot Jobs
Pharmacy Technicians
CareerStaff
WA/OR
Travel and Temp to Perm Opportunities
Club Staffing
Nationwide
Pharmacists and Technicians
Shopko
Nationwide
These hot jobs are provide by:
Rx Career Center logo
Quick Poll
How often have you seen Riluzole (Rilutek) prescribed for ALS ?
• Very often
• Occasionally
• Seldom
• Never
Last Month's Poll
How often have you encountered patients who have developed tardive dyskinesia from antipsychotic drug use?
Very often - 15.9%
Occasionally - 22.7%
Seldom - 36.3%
Never - 25%
 
Continuing Education for Pharmacy Professionals
RxSchool logo Enroll now at www.rxschool.com for the latest online Live and Enduring Continuing Education.
Live On-line Webinars
REMS Drugs & The Practice of Pharmacy: A Program in Law and Risk Management
Sun, October 15 - 12:00–2:00pm/et
Kenneth R. Baker, R.Ph., J.D.
Management of Insomnia and Anxiety Disorders
Mon, October 16 - 8:00–10:00pm/et
Andrew Muzyk, PharmD
Adult Immunizations: A Guide for Pharmacists, Techs & NPs
Tue, October 17 - 6:00–8:00pm/et
Alan P. Agins, PhD & Jody F. Agins, MSN, RNP, FNP/GNP-BC, WCC
Check out our LIVE CE Calendar for additional programs
Featured Distance CE Courses
Pharmacy Spanish
Credits: 12.0
Explore our Distance CE Course Catalog for additional courses
 
Copyright © 2017 Pharmacy Choice - All rights reserved.
                                                           
Previous Newsletters
September 2017
August 2017
June 2017
May 2017
April 2017
March 2017
February 2017
January 2017
December 2016
November 2016
October 2016
September 2016

Advertise
Be seen by thousands of industry eyes.
Advertise in the Pharmacy Choice Newsletter.


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415